Cargando…
Treatment Efficacy for Non-Cardiovascular Chest Pain: A Systematic Review and Meta-Analysis
BACKGROUND: Non-cardiovascular chest pain (NCCP) leads to impaired quality of life and is associated with a high disease burden. Upon ruling out cardiovascular disease, only vague recommendations exist for further treatment. OBJECTIVES: To summarize treatment efficacy for patients presenting with NC...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4128723/ https://www.ncbi.nlm.nih.gov/pubmed/25111147 http://dx.doi.org/10.1371/journal.pone.0104722 |
_version_ | 1782330160777789440 |
---|---|
author | Burgstaller, Jakob M. Jenni, Boris F. Steurer, Johann Held, Ulrike Wertli, Maria M. |
author_facet | Burgstaller, Jakob M. Jenni, Boris F. Steurer, Johann Held, Ulrike Wertli, Maria M. |
author_sort | Burgstaller, Jakob M. |
collection | PubMed |
description | BACKGROUND: Non-cardiovascular chest pain (NCCP) leads to impaired quality of life and is associated with a high disease burden. Upon ruling out cardiovascular disease, only vague recommendations exist for further treatment. OBJECTIVES: To summarize treatment efficacy for patients presenting with NCCP. METHODS: Systematic review and meta-analysis. In July 2013, Medline, Web of Knowledge, Embase, EBSCOhost, Cochrane Reviews and Trials, and Scopus were searched. Hand and bibliography searches were also conducted. Randomized controlled trials (RCTs) evaluating non-surgical treatments in patients with NCCP were included. Exclusion criteria were poor study quality and small sample size (<10 patients per group). RESULTS: Thirty eligible RCT’s were included. Most studies assessed PPI efficacy for gastroesophageal reflux disorders (GERD, n = 10). Two RCTs included musculoskeletal chest pain, seven psychotropic drugs, and eleven various psychological interventions. Study quality was high in five RCTs and acceptable in 25. PPI treatment in patients with GERD (5 RCTs, 192 patients) was more effective than placebo [pooled OR 11.7 (95% CI 5.5 to 25.0, heterogeneity I(2) = 6.1%)]. The pooled OR in GERD negative patients (4 RCTs, 156 patients) was 0.8 (95% CI 0.2 to 2.8, heterogeneity I(2) = 50.4%). In musculoskeletal NCCP (2 RCTs, 229 patients) manual therapy was more effective than usual care but not than home exercise [pooled mean difference 0.5 (95% CI −0.3 to 1.3, heterogeneity I(2) = 46.2%)]. The findings for cognitive behavioral treatment, serotonin reuptake inhibitors, tricyclic antidepressants were mixed. Most evidence was available for cognitive behavioral treatment interventions. LIMITATIONS: Only a small number of studies were available. CONCLUSIONS: Timely diagnostic evaluation and treatment of the disease underlying NCCP is important. For patients with suspected GERD, high-dose treatment with PPI is effective. Only limited evidence was available for most prevalent diseases manifesting with chest pain. In patients with idiopathic NCCP, treatments based on cognitive behavioral principles might be considered. |
format | Online Article Text |
id | pubmed-4128723 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-41287232014-08-12 Treatment Efficacy for Non-Cardiovascular Chest Pain: A Systematic Review and Meta-Analysis Burgstaller, Jakob M. Jenni, Boris F. Steurer, Johann Held, Ulrike Wertli, Maria M. PLoS One Research Article BACKGROUND: Non-cardiovascular chest pain (NCCP) leads to impaired quality of life and is associated with a high disease burden. Upon ruling out cardiovascular disease, only vague recommendations exist for further treatment. OBJECTIVES: To summarize treatment efficacy for patients presenting with NCCP. METHODS: Systematic review and meta-analysis. In July 2013, Medline, Web of Knowledge, Embase, EBSCOhost, Cochrane Reviews and Trials, and Scopus were searched. Hand and bibliography searches were also conducted. Randomized controlled trials (RCTs) evaluating non-surgical treatments in patients with NCCP were included. Exclusion criteria were poor study quality and small sample size (<10 patients per group). RESULTS: Thirty eligible RCT’s were included. Most studies assessed PPI efficacy for gastroesophageal reflux disorders (GERD, n = 10). Two RCTs included musculoskeletal chest pain, seven psychotropic drugs, and eleven various psychological interventions. Study quality was high in five RCTs and acceptable in 25. PPI treatment in patients with GERD (5 RCTs, 192 patients) was more effective than placebo [pooled OR 11.7 (95% CI 5.5 to 25.0, heterogeneity I(2) = 6.1%)]. The pooled OR in GERD negative patients (4 RCTs, 156 patients) was 0.8 (95% CI 0.2 to 2.8, heterogeneity I(2) = 50.4%). In musculoskeletal NCCP (2 RCTs, 229 patients) manual therapy was more effective than usual care but not than home exercise [pooled mean difference 0.5 (95% CI −0.3 to 1.3, heterogeneity I(2) = 46.2%)]. The findings for cognitive behavioral treatment, serotonin reuptake inhibitors, tricyclic antidepressants were mixed. Most evidence was available for cognitive behavioral treatment interventions. LIMITATIONS: Only a small number of studies were available. CONCLUSIONS: Timely diagnostic evaluation and treatment of the disease underlying NCCP is important. For patients with suspected GERD, high-dose treatment with PPI is effective. Only limited evidence was available for most prevalent diseases manifesting with chest pain. In patients with idiopathic NCCP, treatments based on cognitive behavioral principles might be considered. Public Library of Science 2014-08-11 /pmc/articles/PMC4128723/ /pubmed/25111147 http://dx.doi.org/10.1371/journal.pone.0104722 Text en © 2014 Burgstaller et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Burgstaller, Jakob M. Jenni, Boris F. Steurer, Johann Held, Ulrike Wertli, Maria M. Treatment Efficacy for Non-Cardiovascular Chest Pain: A Systematic Review and Meta-Analysis |
title | Treatment Efficacy for Non-Cardiovascular Chest Pain: A Systematic Review and Meta-Analysis |
title_full | Treatment Efficacy for Non-Cardiovascular Chest Pain: A Systematic Review and Meta-Analysis |
title_fullStr | Treatment Efficacy for Non-Cardiovascular Chest Pain: A Systematic Review and Meta-Analysis |
title_full_unstemmed | Treatment Efficacy for Non-Cardiovascular Chest Pain: A Systematic Review and Meta-Analysis |
title_short | Treatment Efficacy for Non-Cardiovascular Chest Pain: A Systematic Review and Meta-Analysis |
title_sort | treatment efficacy for non-cardiovascular chest pain: a systematic review and meta-analysis |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4128723/ https://www.ncbi.nlm.nih.gov/pubmed/25111147 http://dx.doi.org/10.1371/journal.pone.0104722 |
work_keys_str_mv | AT burgstallerjakobm treatmentefficacyfornoncardiovascularchestpainasystematicreviewandmetaanalysis AT jenniborisf treatmentefficacyfornoncardiovascularchestpainasystematicreviewandmetaanalysis AT steurerjohann treatmentefficacyfornoncardiovascularchestpainasystematicreviewandmetaanalysis AT heldulrike treatmentefficacyfornoncardiovascularchestpainasystematicreviewandmetaanalysis AT wertlimariam treatmentefficacyfornoncardiovascularchestpainasystematicreviewandmetaanalysis |